濮阳东方医院治疗阳痿濮阳东方医院割包皮收费正规,濮阳东方医院做人流手术非常专业,濮阳东方技术好,濮阳市东方医院在线预约,濮阳东方医院男科看早泄收费正规,濮阳东方医院男科治阳痿价格比较低,濮阳东方医院男科治早泄技术值得信赖

BEIJING, Sept. 26 (Xinhuanet) -- One of the world's brightest minds aims to bring to the world a new, advanced three-dimensional image technology that will leave other such technology in the shadows."Our new technology will be better than that used in Avatar," says Professor Yau Shing-tung of Harvard University."The image will be more vivid than with technologies used in previous movies. The new technology is not only quicker but cheaper."Yau is one of the world's greatest mathematicians, having won the prestigious Fields Medal. He was once the dean of the department of mathematics at Harvard, and is now a professor there. He is also a visiting professor at Tsinghua University.Professor Yau and his team met professionals from Tsinghua University and Renmin University of China last week, and they discussed possible cooperation to apply the technology in making a demonstration movie using the new technology.Yau and a team started working on the new 3D technology, founded on geometrical principles, at Harvard 10 years ago.What marks it out is the extremely vivid pictures it produces.3D technology is used not only in making movies and in Internet games but in other areas , such as medicine. Movie audiences the world over were awestruck by the technology used in the movie Avatar."After I watched the movie, all I could say was 'Wow'," said Shen Yiren, an IT staff worker in Zhongguancun Science and Technology Park Zone. "3D technology has extended the boundaries of the human imagination."Yau says that six years ago the makers of Avatar had wanted him to cooperate with them but he turned them down."I was not sure that (Avatar) would be such a big success."Avatar's facial caption technology puts points on models' faces while the new technology uses geometric methods, saving time and money, Yau says.

BEIJING, July 26 (Xinhuanet) -- The breast cancer is more deadly to black women than to whites, a new study found.This finding was published online Monday on the "Journal of Clinical Oncology" in the United States.The study was done by the City of Hope, a Comprehensive Cancer Center in Duarte, California.The researchers collected data from more than 4,500 U.S. women in the 35-64 age group who were diagnosed with breast cancer.With the passing of  more than eight years, the researchers found the black women have a three times death rate than white women, after taking obesity and other diseases into account."It’s been long known that breast cancer in African-American women is a far less common disease than in white women. But when it occurs, it seems to be more aggressive and harder to treat," said Dr. Lisa Carey of the University of North Carolina’s Lineberger Comprehensive Cancer Center.But why the situations varied by race, scientists are still exploring the answer.

WELLINGTON, June 7 (Xinhua) -- Scientists in New Zealand have developed a new drug to fight previously untreatable hypoxic cancer tumors, which form in areas of the body starved of oxygen.The researchers at the Auckland University have entered an agreement for the clinical development of CEN-209, which was developed over 10 years of research, said a statement from the university Tuesday.CEN-209 was designed to enhance the effectiveness of radiotherapy and chemotherapy in solid hypoxic tumors, which were resistant to standard cancer therapies, said the statement. In lung cancer patients for example, about half of tumors had hypoxic regions.The new drug worked by damaging the DNA of hypoxic cancer cells, while leaving normal, healthy tissues alone.CEN-209 was designed and created by researchers at the university's Auckland Cancer Society Research Centre (ACSRC), using computer models of drug transport within tumors to accurately predict the anti-tumor activity of the drugs."Our computer models of drug transport developed in-house allowed the synthetic chemists to test their design theories and considerably shortened the discovery process," said Associate Professor Michael Hay, who led the ACSRC research chemists."CEN-209 improves markedly on previous agents in this class in terms of its ability to penetrate tumors, and this is reflected by its improved activity in the laboratory, when combined with long or short courses of radiotherapy," said researcher Professor Bill Wilson.Under the agreement between the university's Auckland UniServices Ltd. and California-based Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc., Centella will have exclusive rights to CEN-209, which it will develop and trial with Cancer Research UK.The work on CEN-209 is the culmination of a program initiated with funding from the U.S. National Cancer Institute, and more recently from the Maurice Wilkins Centre for Biodiscovery. Ongoing preclinical research on CEN-209 and a backup compound was funded by grants from the Auckland Medical Research Foundation, Genesis Oncology Trust and Health Research Council of New Zealand, said the statement.

BEIJING, July 17 (Xinhua) -- Iraqi Prime Minister Nouri al-Maliki arrived in Beijing Sunday night for his first official visit to China as a guest of his Chinese counterpart Wen Jiabao.During al-Maliki's stay in China from Sunday to Thursday, President Hu Jintao will meet with him, and Premier Wen will hold talks with the Iraqi prime minister, Chinese Foreign Ministry spokesman Hong Lei said earlier.China and Iraq share a traditional friendship, Hong said, adding that the two countries have witnessed smooth development of bilateral relations, steadily growing economic cooperation and increasing cultural exchanges."China is ready to work with the international community and to continue to provide assistance for the Iraqi people to improve their livelihoods," said the spokesman.